Inhibition of the 3CL Protease and SARS-CoV‑2 Replication by Dalcetrapib

ACS Omega (Jun 2021)

Affiliations

Eric J Niesor: DalCor Pharmaceuticals, Montreal, Canada
Guy Boivin: Centre Hospitalier Universitaire de Québec, Université Laval, Québec City, Canada
Eric Rhéaume: Montreal Heart Institute, Université de Montréal, Montreal, Canada
Rong Shi: Department of Biochemistry, Microbiology and Bioinformatics, Université Laval, Quebec, Canada
Véronique Lavoie: Montreal Heart Institute, Université de Montréal, Montreal, Canada
Nathalie Goyette: Centre Hospitalier Universitaire de Québec, Université Laval, Québec City, Canada
Marie-Eve Picard: Department of Biochemistry, Microbiology and Bioinformatics, Université Laval, Quebec, Canada
Anne Perez: Hartis-Pharma, Nyon, Switzerland
Fouzia Laghrissi-Thode: DalCor Pharmaceuticals, Montreal, Canada
Jean-Claude Tardif: Montreal Heart Institute, Université de Montréal, Montreal, Canada

Abstract

No abstracts available.